ESR1 and breast carcinoma: For expression level of each gene, we calculated the power a priori, to detect an odds ratio (OR) of 1.2 (or conversely a protective OR of 0.80) given an alpha level of 0.05, the variance explained in the expression level of the gene by the SNP instrument and the sample size of the outcome dataset against overall, ER+ and ER− breast cancer risk, as described previously18.